510(k) Report

510(k) · Cleared

Recalled · Class II · 2014

Target Detachable Coil

K120850510(k) SpecialCleared Apr 17, 201227-day reviewClass II21 CFR 882.5950Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Stryker Neurovascular · HCG Device, Neurovascular Embolization

Cleared on Apr 17, 2012 as substantially equivalent to K093142 (Boston Scientific Corp, 2010) and 2 other predicates after a 27-day review. Its family tree reaches back 10 generations to 1995. It has been recalled once.

Decided
Apr 17, 2012
Review
27 days
Class
Class II
Product code
HCG
Recalls
1
Predicates
3

Its longest line of descent runs back 10 generations to K951256 (1995). 36 ancestors in all, the oldest K860840 (1986). No later device cites it as a predicate yet.

  1. Root · 10 generations backK951256 Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics · 1995
  2. 6 generations between
  3. 3 generations backK093142 Target Detachable Coils and Inzone Detachment SystemBoston Scientific Corp · 2010
  4. 2 generations backK102672 Target Detachable CoilBoston Scientific Corp · 2010
  5. 1 generation backK112385 Traget Detachable CoilStryker Neurovascular · 2011
  6. This deviceK120850 Target Detachable CoilStryker Neurovascular · 2012
Show all 10 generations
  1. Root · 10 generations backK951256 Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics · 1995
  2. 9 generations backK960705 Guglielmi Detachable CoilTarget Therapeutics · 1996
  3. 8 generations backK962503 Guglielmi Detachable CoilTarget Therapeutics · 1996
  4. 7 generations backK971395 Guglielmi Detachable Coil (GDC), Fibered Platinum Coil, .035 Type…Target Therapeutics · 1997
  5. 6 generations backK991139 Guglielmi Detachable (GDC)Boston Scientific, Target · 1999
  6. 5 generations backK042539 GDC-10 360 Degree Coil SR; GDC-10 360 Degree Soft Coil SR; GDC-18…Boston Scientific Corp · 2004 · Recalled
  7. 4 generations backK050700 Matrix Stretch Resistant (SR) CoilsBoston Scientific Corp · 2005 · Recalled
  8. 3 generations backK093142 Target Detachable Coils and Inzone Detachment SystemBoston Scientific Corp · 2010
  9. 2 generations backK102672 Target Detachable CoilBoston Scientific Corp · 2010
  10. 1 generation backK112385 Traget Detachable CoilStryker Neurovascular · 2011
  11. This deviceK120850 Target Detachable CoilStryker Neurovascular · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K951256Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics1995—
−9K960705Guglielmi Detachable CoilTarget Therapeutics1996—
−8K962503Guglielmi Detachable CoilTarget Therapeutics1996—
−7K971395Guglielmi Detachable Coil (GDC), Fibered Platinum Coil, .035 Type, Berenstein…Target Therapeutics1997—
−6K991139Guglielmi Detachable (GDC)Boston Scientific, Target1999—
−5K042539GDC-10 360 Degree Coil SR; GDC-10 360 Degree Soft Coil SR; GDC-18 360 Degree…Boston Scientific Corp20042
−4K050700Matrix Stretch Resistant (SR) CoilsBoston Scientific Corp20051
−3K093142Target Detachable Coils and Inzone Detachment SystemBoston Scientific Corp2010—
−2K102672Target Detachable CoilBoston Scientific Corp2010—
−1K112385Traget Detachable CoilStryker Neurovascular2011—
0 (this device)K120850Target Detachable CoilStryker Neurovascular2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
198830
198910
199120
199250
199420
199520
199620
199710
200020
200220
200330
FIG. 1 — Lineage of K120850, 1995–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HCG device

  1. #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K093142Target Detachable Coils and Inzone Detachment System
Summary page 2
…icate Devices: ________________________________ Reference (Clearance Date) Device K093 142 (4 Feb 2010) Target Detachable Coil and lnZoneg~ Detachment…
Boston Scientific Corp2010—
*K102672Target Detachable Coil
Summary page 2
…(4 Feb 2010) Target Detachable Coil and lnZoneg~ Detachment System K102672 (15 Oct 20 10) Target Detachable Coil KI 12385 ( 15 Sept 2011) Target Detachable Coi…
Boston Scientific Corp2010—
*K112385Traget Detachable Coil
Summary page 5
…eath and new retention clip on BSC branded Target coils since the existing testing previously submitted and approved (K1 12385) covers all Target coil sizes. Accessories: Target Detachable Coils are packaged within a flushing dispenser…
Stryker Neurovascular2011—

Also cleared against K093142: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 22, 2014Class IIZ-0481-2015Process controlUnits of GDC 360 coils, Target coil and Gateway PTA Balloon Catheter were shipped to US customers beyond the expiration date.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 10 months on median.
  • 7 of the 36 ancestors have a recall of any class.
  • 6 other devices also cite its predicate K093142.

How does its category compare?

All HCG devices

HCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · HCG

3in 2025

2007: 82008: 92009: 72010: 82011: 92012: 72013: 72014: 52015: 52016: 72017: 52018: 42019: 12020: 22021: 52022: 32023: 22024: 42025: 32026 (partial year): 4
2007high 9 (2008) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HCG

107in 2025

2007: 50 days median2008: 71 days median2009: 48 days median2010: 72 days median2011: 78 days median2012: 30 days median2013: 67 days median2014: 66 days median2015: 60 days median2016: 37 days median2017: 97 days median2018: 173 days median2021: 103 days median2022: 114 days median2024: 49 days median2025: 107 days median2026 (partial year): 30 days median
2007high 173 (2018) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HCG

1in 2025

2007: 12008: 32010: 22011: 12013: 22014: 42022: 22024: 12025: 1, 1 Class I2026 (partial year): 1
2007high 4 (2014) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · HCG

537in 2025

2007: 3262008: 7302009: 8212010: 8512011: 8942012: 1,1462013: 1,1032014: 1,7292015: 1,5982016: 1,9912017: 2,4942018: 2,0582019: 1,7632020: 1,7542021: 2,2682022: 6632023: 5682024: 5522025: 537
2007high 2,494 (2017) · low 326 (2007)2025

MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078501326
20089713730
20097480821
20108722851
20119781894
201273001,146
201376721,103
201456641,729
201556001,598
201673701,991
201759702,494
2018417302,058
20191—01,763
20202—01,754
2021510302,268
202231142663
20232—0568
20244491552
202531071 (1)537
20264301—

What is it indicated for?

Target Detachable Coils are indicated for the endovascular embolization of:

Intracranial aneurysms

Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae

Arterial and venous embolizations in the peripheral vasculature

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120850: Target Detachable Coil.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K120850

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026